A comparison of clinical practice guidelines in the initial pharmacological management of new-onset epilepsy in adults

Journal of Managed Care Pharmacy

Volumn 12, Issue 1, 2006, Pages 55-60

  Payakachat, Nalin ^a   Summers, Kent H ^a   Barbuto, John P ^b  

^a PURDUE UNIVERSITY   (United States)

^b HealthSouth Rehabilitation Hospital   (United States)

Author keywords

CPGs; Epilepsy; Initial treatment; Policy; Policymakers; Systematic review

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETHOSUXIMIDE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ARTICLE; DRUG EFFICACY; EPILEPSY; HEALTH CARE ORGANIZATION; HUMAN; PRACTICE GUIDELINE; QUALITY OF LIFE; SYSTEMATIC REVIEW; TONIC CLONIC SEIZURE; ADULT; CLINICAL PRACTICE; COMPARATIVE STUDY; REVIEW; STANDARD; UNITED STATES;

ADULT; ANTICONVULSANTS; EPILEPSY; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; UNITED STATES;

EID: 33646582647     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2006.12.1.55     Document Type: Article

References (20)

1. National Center for Chronic Disease Prevention and Health Promotion. Epilepsy: increasing awareness and improving care. Last reviewed September 3, 2004. Available at: http://www.cdc.gov/nccdphp/bb_epilepsy/. Accessed February 23, 2005.
2. Begley CE, Famulari M, Annegers JF, et al. The cost of epilepsy in the United States: an estimate from population-based clinical and survey data. Epilepsia. 2000;41(3):342-51.
3. Kwan P, Brodie MJ. Effectiveness of first antiepileptic drug. Epilepsia. 2001;42(120):1255-60.
4. World Health Organization. World report on knowledge for better health. Chapter 3: Strengthening health research systems. Geneva 2004. Available at: http://www.who.int/rpc/meetings/wr2004/en/print.html. Accessed May 22, 2005.
5. West E, Newton J. Clinical guidelines [editorial]. BMJ. 1997;315:324.
6. National Institute for Health and Clinical Excellence. Guideline development methods, Chapter 15: Updating guidelines and correcting errors. Available at: http://www.nice.org.uk/pdf/GDM_Chapter15_0305.pdf. Accessed February 10, 2005.
7. National Guideline Clearinghouse. Criteria for inclusion of clinical practice guidelines in NGC. Available at: http://www.guideline.gov/about/ inclusion.aspx. Accessed February 10, 2005.
8. National Institute for Health and Clinical Excellence. Technology appraisal guidance 76: newer drugs for epilepsy in adults. Available at: http://www.nice.org.uk/TA076guidance. Accessed July 5, 2005.
9. National Collaborating Centre for Primary Care. The diagnosis and management of the epilepsies in adults and children in primary and secondary care. October 2004. Available at: http://www.rcgp.org.uk/nccpc/docs/ guidelines_epilepsies.pdf, and at http://www.nice.org.uk/pdf/ CG020NICEguideline.pdf. Accessed July 5, 2005.
10. Frost S, Crawford P, Mera S, Chappell B. National statement of good practice for the treatment and care of people who have epilepsy. Joint Epilepsy Council 2002. Available at: http://www.jointepilepsycouncil.org.uk/nsgoodprac. asp. Accessed July 5, 2005.
11. Scottish Intercollegiate Guidelines Network. Diagnosis and management of epilepsy in adults. A national clinical guideline 2003: Addendum released June 2004. Available at: http://www.sign.ac.uk/pdf/sign70.pdf, and at http://www.sign.ac.uk/guidelines/fulltext/70/update.html. Accessed July 5, 2005.
12. French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2004;62:1252-60.
13. Ross SD, Estok R, Chopra S, et al. Management of newly diagnosed patients with epilepsy: a systematic review of the literature. Evidence Report/Technology Assessment No.39 (Contract 290-97-0016 to MetaWorks, Inc.) AHRQ Publication No. 01-E038. Rockville, MD: Agency for Healthcare Research and Quality. September 2001. Available at: http://www.ncbi.nlm.nih.gov/books/bv. fcgi?rid=hstat1.chapter.55359. Accessed July 5, 2005.
14. Facts & Comparisons 4.0. 2005. Wolters Kluwer Health, Inc. Accessed November 29, 2005.
15. National Institute for Health and Clinical Excellence. Technology assessment report: a rapid and systematic review of the clinical effectiveness, tolerability and cost effectiveness of newer drugs for epilepsy in adults. Available at: http://www.nice.org.uk/pdf/HTA_Epilepsy_in_adults.pdf. Accessed July 5, 2005.
16. Kwan P, Brodie MJ. Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy. Neurology. 2003;60(11 suppl 4):S2-S12.
17. French JA, Schachter S. A workshop on antiepileptic drug monotherapy indications. Epilepsia. 2002;43(suppl 10):S3-S27.
18. Beghi E. Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines. Lancet Neurol. 2004;3:618-21.
19. Bero LA. Jadad AR. How consumers and policymakers can use systematic reviews for decision making. Ann Intern Med. 1997;127:37-42.
20. Innvaer S, Vist G, Trommald M, Oxman A. Health policy-makers' perceptions of their use of evidence: a systematic review. J Health Serv Res Policy. 2002;7:239-44.